GGrantIndex
← Leaderboards

Yukari C Manabe

Johns Hopkins University

Google Scholar ↗PubMed ↗ORCID ↗
$10,582,195
Attributed
$14,725,016
Total exposure
10
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6.8M · FY2005–25
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$31,872,498 · 10
CDC$1,894,512 · 1

By mechanism

U54$21,884,373 · 3
D43$4,218,232 · 2
R01$1,951,347 · 1
U01$1,894,512 · 1
R33$1,477,152 · 1
R61$1,422,829 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Communicable Diseases”

Research focus

Communicable DiseasesTrainingDiagnosisFundingTechnologyInfectionProgramsPublic HealthDiagnosticEnsureUgandaSamplingResourcesUniversitiesEvaluationSexually Transmitted DiseasesPerformanceLaboratoriesPoint Of CarePrototypeScientistPreventionTransmission ProcessDevices

Grant awards (53)

Center for Innovative Diagnostics for Infectious Diseases$1,532,027
U54 · FY2025 · EB · contact PI
Quantitative Assessment of the DPP Syphilis TnT assay in infection and treatment response$426,625
R21 · FY2025 · AI · contact PI
Administrative Core$314,538
U54 · FY2025 · EB · contact PI
RADXHIV VIRAL LOAD$161,295
U54 · FY2025 · EB · contact PI
Center for Innovative Diagnostics for Infectious Diseases$1,537,364
U54 · FY2024 · EB · contact PI
Streamlined 15-min HIV Viral Load Self-Testing Using Finger-Stick Blood$723,594
R33 · FY2024 · AI
Center for Innovative Diagnostics for Infectious Diseases$600,000
U54 · FY2024 · EB · contact PI
Administrative Core$471,147
U54 · FY2024 · EB · contact PI
Center for Innovative Diagnostics for Infectious Diseases$1,545,823
U54 · FY2023 · EB · contact PI
Administrative Core$1,130,660
U54 · FY2023 · EB · contact PI
Streamlined 15-min HIV Viral Load Self-Testing Using Finger-Stick Blood$753,558
R33 · FY2023 · AI
HIV CO-INFECTIONS IN UGANDA$300,827
D43 · FY2023 · TW
HIV CO-INFECTIONS IN UGANDAAdministrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)$131,943
D43 · FY2023 · TW
HIV CO-INFECTIONS IN UGANDA$82,057
D43 · FY2023 · TW
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases$2,105,293
U54 · FY2022 · EB · contact PI
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases$1,494,231
U54 · FY2022 · EB · contact PI
RADx Tech HIV$1,199,776
U54 · FY2022 · EB · contact PI
Supporting RADx Technology Development: Leveraging International Networks and Clinical Context$1,032,628
U54 · FY2022 · EB · contact PI
Streamlined 15-min HIV Viral Load Self-Testing Using Finger-Stick Blood$472,204
R61 · FY2022 · AI
HIV CO-INFECTIONS IN UGANDA$300,466
D43 · FY2022 · TW
Clin-Trans-Valid-IDI$182,329
U54 · FY2022 · EB · contact PI
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases$1,515,302
U54 · FY2021 · EB · contact PI
Streamlined 15-min HIV Viral Load Self-Testing Using Finger-Stick Blood$475,479
R61 · FY2021 · AI
HIV CO-INFECTIONS IN UGANDA$300,823
D43 · FY2021 · TW
Clin-Trans-Valid-IDI$183,477
U54 · FY2021 · EB · contact PI
HIV CO-INFECTIONS IN UGANDA$80,674
D43 · FY2021 · TW
Ending the HIV Epidemic through Point-of-Care Technologies (EHPOC): Performance Evaluation of Novel POC HIV Tests in Baltimore$1,644,512
U01 · FY2020 · PS · contact PI
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases$1,630,349
U54 · FY2020 · EB · contact PI
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases$1,529,375
U54 · FY2020 · EB · contact PI
Streamlined 15-min HIV Viral Load Self-Testing Using Finger-Stick Blood$475,146
R61 · FY2020 · AI
HIV CO-INFECTIONS IN UGANDA$300,827
D43 · FY2020 · TW
PS16-004, Ending the HIV Epidemic through Point-of-Care Technologies (EHPOC): Performance Evaluation of Novel POC HIV Tests in Baltimore$250,000
U01 · FY2020 · PS · contact PI
Clin-Trans-Valid-IDI$184,081
U54 · FY2020 · EB · contact PI
HIV CO-INFECTIONS IN UGANDA$87,859
D43 · FY2020 · TW
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases$1,556,539
U54 · FY2019 · EB · contact PI
Clin-Trans-Valid-IDI$185,358
U54 · FY2019 · EB · contact PI
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases$1,601,992
U54 · FY2018 · EB
HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis.$292,517
D43 · FY2018 · TW · contact PI
Clin-Trans-Valid-IDI$190,789
U54 · FY2018 · EB · contact PI
The UJMT Global Consortium: building research capacity through mentored training$1,000,000
D43 · FY2017 · TW
HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis.$289,221
D43 · FY2017 · TW · contact PI
The UJMT Global Consortium: building research capacity through mentored training$214,469
D43 · FY2017 · TW
HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis.$282,804
D43 · FY2016 · TW · contact PI
HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis.$285,538
D43 · FY2015 · TW · contact PI
HIV Co-infections in Uganda: TB, Crypotococcus, and Viral Hepatitis.$268,207
D43 · FY2014 · TW · contact PI
LATENCY AND REACTIVATION TUBERCULOSIS$470,430
R01 · FY2006 · HL · contact PI
LATENCY AND REACTIVATION TUBERCULOSIS$549,634
R01 · FY2005 · HL
LATENCY AND REACTIVATION TUBERCULOSIS$454,256
R01 · FY2004 · HL
LATENCY AND REACTIVATION TUBERCULOSIS$477,027
R01 · FY2003 · HL
IRON REGULATION &VIRULENCE--MYCOBACTERIUM TUBERCULOSIS$125,685
K08 · FY2003 · AI
IRON REGULATION &VIRULENCE--MYCOBACTERIUM TUBERCULOSIS$125,685
K08 · FY2002 · AI
IRON REGULATION &VIRULENCE--MYCOBACTERIUM TUBERCULOSIS$125,685
K08 · FY2001 · AI
IRON REGULATION &VIRULENCE--MYCOBACTERIUM TUBERCULOSIS$114,885
K08 · FY2000 · AI